As of close of business last night, Hoth Therapeutics Inc’s stock clocked out at $1.65, up 13.01% from its previous closing price of $1.46. In other words, the price has increased by $+0.1900 from its previous closing price. On the day, 634691 shares were traded.
Ratios:
To gain a deeper understanding of HOTH’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.63 and its Current Ratio is at 7.63. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, The Benchmark Company on October 15, 2019, initiated with a Speculative Buy rating and assigned the stock a target price of $10.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HOTH now has a Market Capitalization of 7.13M and an Enterprise Value of -4.72M.
Stock Price History:
Over the past 52 weeks, HOTH has reached a high of $4.30, while it has fallen to a 52-week low of $0.99. The 50-Day Moving Average of the stock is 1.3222, while the 200-Day Moving Average is calculated to be 1.7894.
Shares Statistics:
It appears that HOTH traded 559.40K shares on average per day over the past three months and 2.15M shares per day over the past ten days. A total of 4.35M shares are outstanding, with a floating share count of 4.31M. Insiders hold about 0.93% of the company’s shares, while institutions hold 7.07% stake in the company. Shares short for HOTH as of Feb 29, 2024 were 76.36k with a Short Ratio of 0.14, compared to 113.35k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.76% and a Short% of Float of 1.77%.
Earnings Estimates
As of right now, 2 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.51 for the current quarter, with a high estimate of -$0.49 and a low estimate of -$0.53, while EPS last year was -$2.86. The consensus estimate for the next quarter is -$0.54, with high estimates of -$0.54 and low estimates of -$0.54.
Analysts are recommending an EPS of between -$2.43 and -$2.58 for the fiscal current year, implying an average EPS of -$2.5. EPS for the following year is -$1.89, with 2 analysts recommending between -$1.69 and -$2.09.
